133 related articles for article (PubMed ID: 7780952)
21. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
Kim R; Tanabe K; Emi M; Uchida Y; Osaki A; Toge T
Int J Oncol; 2005 Apr; 26(4):1025-31. PubMed ID: 15753998
[TBL] [Abstract][Full Text] [Related]
22. Effects of prostaglandin E(2) on proliferation and apoptosis of epithelial ovarian cancer cells.
Munkarah AR; Morris R; Baumann P; Deppe G; Malone J; Diamond MP; Saed GM
J Soc Gynecol Investig; 2002; 9(3):168-73. PubMed ID: 12009392
[TBL] [Abstract][Full Text] [Related]
23. Down-regulation of Bcl-2 enhances estrogen apoptotic action in long-term estradiol-depleted ER(+) breast cancer cells.
Song RX; Zhang Z; Mor G; Santen RJ
Apoptosis; 2005 May; 10(3):667-78. PubMed ID: 15909128
[TBL] [Abstract][Full Text] [Related]
24. Siegesbeckia glabrescens induces apoptosis with different pathways in human MCF-7 and MDA-MB-231 breast carcinoma cells.
Jun SY; Choi YH; Shin HM
Oncol Rep; 2006 Jun; 15(6):1461-7. PubMed ID: 16685380
[TBL] [Abstract][Full Text] [Related]
25. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.
Henkels KM; Turchi JJ
Cancer Res; 1999 Jul; 59(13):3077-83. PubMed ID: 10397248
[TBL] [Abstract][Full Text] [Related]
26. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
[TBL] [Abstract][Full Text] [Related]
27. Interconnections between E2-dependent regulation of cell cycle progression and apoptosis in MCF-7 tumors growing on nude mice.
Truchet I; Jozan S; Guerrin M; Mazzolini L; Vidal S; Valette A
Exp Cell Res; 2000 Feb; 254(2):241-8. PubMed ID: 10640422
[TBL] [Abstract][Full Text] [Related]
28. Anti-apoptotic action of zearalenone in MCF-7 cells.
Yu Z; Zhang L; Wu D; Liu F
Ecotoxicol Environ Saf; 2005 Nov; 62(3):441-6. PubMed ID: 16216639
[TBL] [Abstract][Full Text] [Related]
29. Quantitative analysis of expression levels of bax, bcl-2, and survivin in cancer cells during cisplatin treatment.
Ikeguchi M; Nakamura S; Kaibara N
Oncol Rep; 2002; 9(5):1121-6. PubMed ID: 12168083
[TBL] [Abstract][Full Text] [Related]
30. ALCAM/CD166 protects breast cancer cells against apoptosis and autophagy.
Jezierska A; Matysiak W; Motyl T
Med Sci Monit; 2006 Aug; 12(8):BR263-73. PubMed ID: 16865058
[TBL] [Abstract][Full Text] [Related]
31. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung.
Shabnam MS; Srinivasan R; Wali A; Majumdar S; Joshi K; Behera D
Lung Cancer; 2004 Aug; 45(2):181-8. PubMed ID: 15246189
[TBL] [Abstract][Full Text] [Related]
32. Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells.
Chen HW; Huang HC
Br J Pharmacol; 1998 Jul; 124(6):1029-40. PubMed ID: 9720770
[TBL] [Abstract][Full Text] [Related]
33. [Effects of zearalenone on proliferation and apoptosis in MCF-7 cells].
Yu ZL; Zhang LS; Wu DS
Zhonghua Yu Fang Yi Xue Za Zhi; 2005 Sep; 39(5):328-31. PubMed ID: 16266544
[TBL] [Abstract][Full Text] [Related]
34. Calycosin stimulates proliferation of estrogen receptor-positive human breast cancer cells through downregulation of Bax gene expression and upregulation of Bcl-2 gene expression at low concentrations.
Chen J; Xiong WB; Xiong Y; Wu YY; Chen XJ; Shao ZJ; Liu LT; Kuang WJ; Tan XS; Zhou LM
JPEN J Parenter Enteral Nutr; 2011 Nov; 35(6):763-9. PubMed ID: 21799188
[TBL] [Abstract][Full Text] [Related]
35. Antagonism between estradiol and progestin on Bcl-2 expression in breast-cancer cells.
Kandouz M; Siromachkova M; Jacob D; Chretien Marquet B; Therwath A; Gompel A
Int J Cancer; 1996 Sep; 68(1):120-5. PubMed ID: 8895551
[TBL] [Abstract][Full Text] [Related]
36. Down-regulation of bcl-xs gene expression in rat thymocytes by dexamethasone.
Sakamoto T; Repasky WT; Chen J; Hirata A; Hirata F
Biochem Biophys Res Commun; 1995 Oct; 215(2):511-6. PubMed ID: 7487985
[TBL] [Abstract][Full Text] [Related]
37. Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells.
Teixeira C; Reed JC; Pratt MA
Cancer Res; 1995 Sep; 55(17):3902-7. PubMed ID: 7641210
[TBL] [Abstract][Full Text] [Related]
38. The effects of CD59 gene as a target gene on breast cancer cells.
Li B; Chu X; Gao M; Xu Y
Cell Immunol; 2011; 272(1):61-70. PubMed ID: 22000275
[TBL] [Abstract][Full Text] [Related]
39. Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-induced apoptosis of human breast cancer MCF-7 cells.
Huang Y; Ray S; Reed JC; Ibrado AM; Tang C; Nawabi A; Bhalla K
Breast Cancer Res Treat; 1997 Jan; 42(1):73-81. PubMed ID: 9116321
[TBL] [Abstract][Full Text] [Related]
40. Differential sensitivity of MCF-7 and LCC2 cells, to multiple growth inhibitory agents: possible relation to high bcl-2/bax ratio?
Lilling G; Hacohen H; Nordenberg J; Livnat T; Rotter V; Sidi Y
Cancer Lett; 2000 Dec; 161(1):27-34. PubMed ID: 11078910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
